Raymond Prudo-Chlebosz
CIK: 0001653262
Associated companies
Transaction History
| AKTX | ▲ Buy | Grant | 446,428 | $500K | 3/6/2025 | View on chart |
| AKTX | ▲ Buy | Grant | 419,286,000 | $503K | 12/2/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 1,326,258,000 | $1.2M | 5/31/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Akari Therapeutics Files New Patent Application
Akari Therapeutics has submitted a new patent application to expand its intellectual property portfolio. This move is relevant as it aims to strengthen the company's long-term position in its therapeutic areas. The stock currently trades well below its 52-week high, reflecting the significant volatility seen in the sector.
Akari Therapeutics Files New Patent Application. Akari Therapeutics has submitted a new patent application to expand its intellectual property portfolio. This move is relevant as it aims to strengthen the company's long-term position in its therapeutic areas. The stock currently trades well below its 52-week high, reflecting the significant volatility seen in the sector.